GRI Bio, Inc. (GRI)

GRI Bio Statistics

Total Valuation

GRI Bio has a market cap or net worth of $4.23 million. The enterprise value is -$800,288.

Market Cap	4.23M
Enterprise Value	-800,288

Important Dates

The next estimated earnings date is Friday, November 14, 2025, after market close.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

GRI Bio has 2.52 million shares outstanding. The number of shares has increased by 5,323.57% in one year.

Current Share Class	2.52M
Shares Outstanding	2.52M
Shares Change (YoY)	+5,323.57%
Shares Change (QoQ)	+319.67%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	1.83%
Float	2.51M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.26
P/TBV Ratio	1.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.41, with a Debt / Equity ratio of 0.03.

Current Ratio	2.41
Quick Ratio	2.22
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -248.92% and return on invested capital (ROIC) is -151.47%.

Return on Equity (ROE)	-248.92%
Return on Assets (ROA)	-98.68%
Return on Invested Capital (ROIC)	-151.47%
Return on Capital Employed (ROCE)	-298.01%
Revenue Per Employee	n/a
Profits Per Employee	-$2.98M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -90.50% in the last 52 weeks. The beta is -1.44, so GRI Bio's price volatility has been lower than the market average.

Beta (5Y)	-1.44
52-Week Price Change	-90.50%
50-Day Moving Average	1.84
200-Day Moving Average	3.15
Relative Strength Index (RSI)	42.23
Average Volume (20 Days)	187,295

Short Selling Information

The latest short interest is 247,643, so 9.85% of the outstanding shares have been sold short.

Short Interest	247,643
Short Previous Month	255,041
Short % of Shares Out	9.85%
Short % of Float	9.85%
Short Ratio (days to cover)	0.67

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-10.03M
Pretax Income	-10.01M
Net Income	-11.92M
EBITDA	-10.03M
EBIT	-10.03M
Earnings Per Share (EPS)	-$13.95

Balance Sheet

The company has $5.12 million in cash and $96,000 in debt, giving a net cash position of $5.03 million or $2.00 per share.

Cash & Cash Equivalents	5.12M
Total Debt	96,000
Net Cash	5.03M
Net Cash Per Share	$2.00
Equity (Book Value)	3.32M
Book Value Per Share	1.33
Working Capital	3.27M

Cash Flow

Operating Cash Flow	-9.17M
Capital Expenditures	n/a
Free Cash Flow	-9.17M
FCF Per Share	-$3.65

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

GRI Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5,323.57%
Shareholder Yield	-5,323.57%
Earnings Yield	-282.06%
FCF Yield	-216.98%

Analyst Forecast

The average price target for GRI Bio is $22.50, which is 1,239.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.50
Price Target Difference	1,239.29%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-71.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on February 24, 2025. It was a reverse split with a ratio of 1:17.

Last Split Date	Feb 24, 2025
Split Type	Reverse
Split Ratio	1:17

Scores

Altman Z-Score	n/a
Piotroski F-Score	1